logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Gonadotropin Releasing Hormone Receptor Agonist class drugs

    FiltersReset Filters
    15 results

    • camcevi

      (LEUPROLIDE)
      Accord BioPharma, Inc.
      Usage: CAMCEVI is indicated for the treatment of adult patients with advanced prostate cancer.

    • eligard

      (Leuprolide Acetate)
      TOLMAR Inc.
      Usage: ELIGARD® is indicated for the palliative treatment of advanced prostate cancer.

    • fensolvi

      (Leuprolide Acetate)
      TOLMAR Inc.
      Usage: FENSOLVI® is indicated for treating central precocious puberty (CPP) in pediatric patients aged 2 years and older.

    • leuprolide acetate

      (leuprolide acetate)
      UBI Pharma Inc.
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • leuprolide acetate

      (Leuprolide Acetate)
      VGYAAN Pharmaceuticals LLC
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • leuprolide acetate

      (Leuprolide Acetate)
      Sandoz Inc
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • leuprolide acetate

      (leuprolide acetate)
      Amneal Pharmaceuticals LLC
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • leuprolide acetate

      (leuprolide acetate)
      PAI Holdings, LLC dba PAI Pharma
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • leuprolide acetate

      (Leuprolide Acetate)
      NorthStar RxLLC
      Usage: Leuprolide acetate injection is indicated for the palliative treatment of advanced prostatic cancer.

    • lupron depot

      (leuprolide acetate)
      AbbVie Inc.
      Usage: LUPRON DEPOT 11.25 mg is indicated for managing endometriosis, including pain relief and lesion reduction, as well as for preoperative anemia improvement in women with uterine leiomyomata (fibroids), used with iron therapy. It is not meant for prolonged use or specific combinations beyond stated limits.